{"id":"W2492668869","doi":"10.1158/1538-7445.am2016-ct142","title":"Abstract CT142: A phase I open-label, dose escalation study of a novel peptide (SOR-C13) antagonistic to the TRPV6 ion channel in patients with advanced solid tumor cancers","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Ion Channels and Receptors","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Employment and Social Development Canada; London Health Sciences Centre; Juravinski Cancer Centre","funders":"","keywords":"Tolerability; Medicine; Nausea; Adverse effect; Internal medicine; Constipation; Anemia; Gastroenterology; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009463892,0.001297556,0.001569383,0.0003985326,0.000398705,0.0006962247,0.0007849637,0.0009069942,0.003893774],"category_scores_gemma":[0.0005026069,0.0004817074,0.0008711407,0.0003943113,0.000769529,0.0005846095,0.0002632029,0.002454455,0.0007516153],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007595483,"about_ca_system_score_gemma":0.001640845,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001266157,"about_ca_topic_score_gemma":0.003276883,"domain_scores_codex":[0.9997217,0.0001123655,0.00001649027,0.00005632993,0.00003553775,0.00005756713],"domain_scores_gemma":[0.9995738,0.000054239,0.00008393222,0.00003366222,0.00004484349,0.0002096133],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5070375,0.1257478,0.007168044,0.001216353,0.001212967,0.0003282622,0.0004279667,0.004535604,0.2627442,0.0002883111,0.004454162,0.08483888],"study_design_scores_gemma":[0.2438398,0.7270055,0.01189436,0.00002775588,0.0003519676,0.0002812585,0.00007444687,0.001476935,0.01289777,0.0001002574,0.00201471,0.00003522146],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951491,0.0008330233,0.0005227192,0.0001448847,0.00004946975,0.001696948,0.0006864151,0.00008387294,0.0008335788],"genre_scores_gemma":[0.9911702,0.0007653874,0.001753613,0.0003524953,0.00008146931,0.001743371,0.001400808,0.00002655271,0.002706102],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003893774,"threshold_uncertainty_score":0.01302594,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1430413605159154,"score_gpt":0.4414717890103327,"score_spread":0.2984304284944173,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}